$10.2M NIH grant awarded to study risk factors for malignant arrhythmias in mitral valve prolapse

Researchers at the Icahn School of Medicine at Mount Sinai have been awarded a $10.2 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to investigate risk factors for malignant arrhythmias in mitral valve prolapse.

Arbital Health Acquires Actuarial Firm & Secures $10M for Value-Based Care Adjudication

Arbital Health What You Should Know: – Arbital Health, a rising star in the value-based care space, announced a significant double play today, acquiring leading

January 4, 2024

IGM Biosciences cuts 22% of workforce, axes hematologic oncology program

IGM Biosciences is not only reducing its workforce by about 22%, but it is also axing its clinical development program in hematologic oncology as well

December 7, 2023

AI model predicts Alzheimer’s progression with new insights into racial and sex-based disparities

Researchers developed a deep learning model that predicts Alzheimer’s progression with high accuracy, highlighting differences in disease progression across race and sex.

November 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.